Form 8-K INTEGRA LIFESCIENCES For: Nov 03

Go back to Form 8-K INTEGRA LIFESCIENCES For: Nov 03

Integra LifeSciences (IART) Tops Q3 EPS by 2c; Will Spin Spine Business

November 3, 2014 4:07 PM EST

Integra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.76, $0.02 better than the analyst estimate of $0.74. Revenue for the quarter came in at $229.7 million versus the consensus estimate of $233.5 million.

The company also announced that it plans to spin off its Spine business to Integra shareholders on a tax-free basis. The spin-off will create a new publicly traded company called SeaSpine focused on developing, marketing and selling spine hardware and orthobiologics. Integra will continue to focus on providing specialty surgical solutions, orthopedics and tissue technologies to surgeons. The portfolio realignment is part of a larger... More